What can we learn from negative results in clinical trials for proliferative vitreoretinopathy?

作     者：Peter Wiedemann 

作者机构：Medical FacultyLeipzig UniversityLeipzig 04103Germany 

出 版 物：《International Journal of Ophthalmology(English edition)》 (国际眼科杂志（英文版）)

年 卷 期：2022年第15卷第9期

页      面：1413-1415页

核心收录：

学科分类：1002[医学-临床医学] 100212[医学-眼科学] 10[医学] 

主　　题：proliferative surgery clinical 

摘      要：INTRODUCTION Since the beginning of vitreoretinal surgery proliferative vitreoretinopathy(PVR)has been a constant *** is the major cause for surgical failure after primary rhegmatogenous retinal detachment(RRD)resulting in multiple reoperations and vision *** far,there is no proven therapy to treat or prevent PVR.